In:
Journal of Arrhythmia, Wiley, Vol. 36, No. 4 ( 2020-08), p. 789-793
Abstract:
We meta‐analyzed the efficacy and safety of catheter (CA) vs thoracoscopic (TA) ablation for atrial fibrillation (AF). Methods PubMed, Embase, and Cochrane databases were searched until 31/12/2019 for relevant randomized trials and subsequent pooled analyses. Results In six trials totaling 465 patients (254 CA/211 TA), 1‐year AF recurrences were higher for CA (46% vs 26%, odds ratio 2.90 [95% CI 1.32‐6.38]), whereas total adverse events were lower (10% vs 25%, 0.35 [0.14‐0.86] , respectively). Conclusion CA has lower efficacy but higher safety than TA. CA should remain the first‐line AF ablation strategy, and TA reserved for selected CA‐resistant patients where rhythm control is clinically necessary.
Type of Medium:
Online Resource
ISSN:
1880-4276
,
1883-2148
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2696593-8
Permalink